Welcome to our dedicated page for MINERVA SURGICAL news (Ticker: UTRS), a resource for investors and traders seeking the latest updates and insights on MINERVA SURGICAL stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MINERVA SURGICAL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MINERVA SURGICAL's position in the market.
Minerva Surgical has launched AUBandMe.com at the 50th Global Congress of the American Association of Gynecologic Laparoscopists, focusing on Abnormal Uterine Bleeding (AUB) treatment education. AUB affects 1 in 3 women, often leading to untreated conditions and significant quality of life deterioration. The initiative aims to empower women with knowledge about available non-hormonal treatments and improve their treatment options. CEO Dave Clapper emphasized the need for better awareness and solutions for women suffering from heavy periods.
Minerva Surgical has successfully closed its initial public offering, selling 6,250,000 shares at $12.00 each, raising approximately $75.0 million. The offering was managed by J.P. Morgan, Piper Sandler, UBS, and SVB Leerink. The proceeds will support the company's development of minimally invasive solutions for Abnormal Uterine Bleeding (AUB), targeting a market need for alternatives to hysterectomy. The registration statement for this offering was effective as of October 21, 2021. This press release serves as a notice and does not constitute an offer or solicitation.
Minerva Surgical, a company specializing in women's healthcare, has priced its initial public offering (IPO) at $12.00 per share, totaling $75.0 million for 6,250,000 shares. Trading on the Nasdaq under the symbol UTRS is set to commence on October 22, 2021, with the offering expected to close on October 26, 2021. The underwriters have a 30-day option to purchase an additional 937,500 shares. This IPO aims to fund the continued development of minimally invasive solutions for abnormal uterine bleeding, a significant concern for women's health.